Sally Beauty Beats on Q4 EPS Growth, Guides FY27 EPS to $2.20-$2.30
SBH sits 69% above its 52-week low of $11.54.
Summary
Sally Beauty closed fiscal 2026 with fourth-quarter adjusted EPS of $0.62, up 13% year over year, and GAAP diluted EPS of $0.60, up 22%. Sales were $953 million, up 0.6%, with comparable sales up 0.9% — modest top-line growth but operating margin expanded 130 basis points to 9.7% on lower SG&A. Full-year adjusted EPS came in at $2.08, up 9%, on sales of $3.73 billion. The company generated $323 million of operating cash flow and $210 million of free cash flow, repaid $80 million of term loan B, and bought back $113 million of stock, including 2.6 million shares repurchased for $42 million in the fourth quarter, ending the year at 1.4x net leverage. Initial FY27 guidance calls for sales of $3.77-$3.81 billion, comps of +1% to +2%, and adjusted EPS of $2.20-$2.30; Q1 guidance is $0.48-$0.52 on sales of $945-$955 million. The stock sits near its 52-week high of $19.60, so the FY27 EPS midpoint of $2.25 implies roughly 8.7x — the market will want to see whether the margin gains hold as BSG comps remain negative at -0.6% in Q4.
At the time of this announcement, SBH was trading at $19.49 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $11.54 to $19.60. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.